A variant of the SLC10A2 gene encoding the apical sodium-dependent bile acid transporter is a risk factor for gallstone disease

• Published in: PloS one Vol. 4; no. 10; p. e7321
• Main Authors: Renner, Olga, Harsch, Simone, Schaeffeler, Elke, Winter, Stefan, Schwab, Matthias, Krawczyk, Marcin, Rosendahl, Jonas, Wittenburg, Henning, Lammert, Frank, Stange, Eduard F
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 13.10.2009; Public Library of Science (PLoS)
• Subjects: Acids; Alleles; Apolipoproteins; Base pairs; Bile; Case-Control Studies; Cholesterol; Cohort Studies; Deoxycholic acid; Deoxyribonucleic acid; Disease susceptibility; DNA; DNA Mutational Analysis; Exons; Female; Gallstones; Gallstones - genetics; Gallstones - metabolism; Gastroenterology and Hepatology/Biliary Tract; Gene expression; Genes; Genetic diversity; Genetic variance; Genetic Variation; Genetics and Genomics/Genetics of Disease; Genotype; Health risks; Heterozygote; Humans; Leukocytes; Lipids; Male; Mass spectrometry; Mass spectroscopy; Molecular Biology; Mutation; Nucleotide sequence; Organic Anion Transporters, Sodium-Dependent - genetics; Organic Anion Transporters, Sodium-Dependent - metabolism; Patients; Population (statistical); Risk Factors; Rodents; Single nucleotide polymorphisms; Single-nucleotide polymorphism; Sodium; Statistical analysis; Studies; Symporters - genetics; Symporters - metabolism; Transporter; Ultrasound; Germany
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0007321

Cholelithiasis is a multifactorial process and several mechanisms of gallstone formation have been postulated. As one of these mechanisms, a decreased expression of the ileal apical sodium-dependent bile acid transporter gene SLC10A2 in gallstone carriers was described previously. In this study the SLC10A2 gene was investigated to identify novel genetic variants and their association with gallstone formation. Study subjects were selected with the presence or absence of gallstones confirmed by ultrasound and medical history. Genomic DNA was obtained from blood leukocytes. Sequence analysis was performed of all six exonic and flanking regions as well as of 2,400 base pairs of the SLC10A2 promoter in a cohort of gallstone carriers and control subjects from Stuttgart, Germany. Genotype frequencies of newly identified genetic variants (n = 6) and known single nucleotide polymorphisms (n = 24) were established using MALDI-TOF mass spectrometry. Six new genetic variants were found within the SLC10A2 gene. Although none of the variants was linked to gallstone disease in the Stuttgart cohort overall, the minor allele of SNP rs9514089 was more prevalent in male non-obese gallstone carriers (p = 0.06680, OR = 11.00). In a separate population from Aachen, Germany, the occurrence of rs9514089 was two-fold higher in gallstone patients (22%) than in corresponding controls (11%) (p = 0.00995, OR = 2.19). In the pooled Aachen/Stuttgart cohort rs9514089 was highly significantly linked to cholelithiasis (p = 0.00767, OR = 2.04). A more frequent occurrence was observed for male gallstone carriers (22%) compared to controls (9%) (p = 0.01017, OR = 2.99), for the total normal weight group (p = 0.00754, OR = 2.90), and for male non-obese gallstone patients (p = 0.01410, OR = 6.85). Moreover, for the minor allele of rs9514089 an association with low plasma cholesterol levels was found especially in gallstone carriers (p = 0.05). We have identified SLC10A2 as a novel susceptibility gene for cholelithiasis in humans. Comprehensive statistical analysis provides strong evidence that rs9514089 is a genetic determinant especially in male non-obese gallstone carriers. The minor allele of rs9514089 is related to differences in plasma cholesterol levels among the subjects.